Robert W. Schnepp, Ph.D.
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Robert Schnepp"Parents
Sign in to add mentor| Xianxin Hua | grad student | 2006 | Penn | |
| (The tumor suppressor menin promotes apoptosis and inhibits cell cycle progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shahab SW, Roggeveen CM, Sun J, et al. (2023) The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. Molecular Oncology |
| Shields CE, Potlapalli S, Cuya-Smith SM, et al. (2021) Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Molecular Oncology |
| Shim J, Lee JY, Jonus HC, et al. (2020) YAP-mediated repression of HRK regulates tumor growth, therapy response, and survival under tumor environmental stress in neuroblastoma. Cancer Research |
| Schnepp RW, Khurana P, Attiyeh EF, et al. (2015) A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell. 28: 599-609 |
| Healy JR, Schnepp RW, Hart LS, et al. (2015) Abstract B34: Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma Molecular Cancer Research. 13 |
| Schnepp RW, Khurana P, Attiyeh EF, et al. (2015) Abstract 4734: A LIN28B/RAN/AURKA signaling network promotes neuroblastoma tumorigenesis Cancer Research. 75: 4734-4734 |
| Schnepp R, Hart L, Raman P, et al. (2014) Abstract B75: Defining the antitumor activity and sensitivity profiles of BET inhibitors in neuroblastoma Cancer Research. 74 |
| Rader J, Russell MR, Hart LS, et al. (2013) Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6173-82 |
| Schnepp RW, Maris JM. (2013) Targeting MYCN: a good BET for improving neuroblastoma therapy? Cancer Discovery. 3: 255-7 |
| Schnepp RW, Attiyeh EF, Gagliardi ME, et al. (2013) Abstract 3809: The role ofLIN28BandRANin promoting neuroblastoma tumorigenesis. Cancer Research. 73: 3809-3809 |